196 related articles for article (PubMed ID: 37478900)
21. Long-term follow-up of leucoderma patients treated with transplants of autologous cultured melanocytes, ultrathin epidermal sheets and basal cell layer suspension.
Olsson MJ; Juhlin L
Br J Dermatol; 2002 Nov; 147(5):893-904. PubMed ID: 12410698
[TBL] [Abstract][Full Text] [Related]
22. Repigmentation of vitiligo-associated leukotrichia after autologous, non-cultured melanocyte-keratinocyte transplantation.
Al Jasser MI; Ghwish B; Al Issa A; Mulekar SV
Int J Dermatol; 2013 Nov; 52(11):1383-6. PubMed ID: 23834588
[TBL] [Abstract][Full Text] [Related]
23. Non-cultured melanocyte-keratinocyte transplantation for the treatment of vitiligo: a clinical trial in an Iranian population.
Toossi P; Shahidi-Dadras M; Mahmoudi Rad M; Fesharaki RJ
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1182-6. PubMed ID: 21214632
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
Mulekar SV
Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183
[TBL] [Abstract][Full Text] [Related]
25. Treatment of "stable" vitiligo by Timedsurgery and transplantation of cultured epidermal autografts.
Guerra L; Capurro S; Melchi F; Primavera G; Bondanza S; Cancedda R; Luci A; De Luca M; Pellegrini G
Arch Dermatol; 2000 Nov; 136(11):1380-9. PubMed ID: 11074702
[TBL] [Abstract][Full Text] [Related]
26. Dermabrasion Versus Microneedling in Transplantation of Autologous Noncultured Melanocyte-Keratinocyte Cell Suspension in Patients With Vitiligo.
Hasan MS; Almohsen AM; Nasr MI; Rageh MA
Dermatol Surg; 2023 May; 49(5):494-502. PubMed ID: 36892550
[TBL] [Abstract][Full Text] [Related]
27. Ratio of size of recipient and donor areas in treatment of vitiligo by autologous cultured melanocyte transplantation.
Hong WS; Hu DN; Qian GP; McCormick SA; Xu AE
Br J Dermatol; 2011 Sep; 165(3):520-5. PubMed ID: 21564070
[TBL] [Abstract][Full Text] [Related]
28. Stable vitiligo treated by a combination of low-dose oral pulse betamethasone and autologous, noncultured melanocyte-keratinocyte cell transplantation.
Mulekar SV
Dermatol Surg; 2006 Apr; 32(4):536-41. PubMed ID: 16681662
[TBL] [Abstract][Full Text] [Related]
29. Dermal mesenchymal stem cells (DMSCs) inhibit skin-homing CD8+ T cell activity, a determining factor of vitiligo patients' autologous melanocytes transplantation efficiency.
Zhou MN; Zhang ZQ; Wu JL; Lin FQ; Fu LF; Wang SQ; Guan CP; Wang HL; Xu A
PLoS One; 2013; 8(4):e60254. PubMed ID: 23577097
[TBL] [Abstract][Full Text] [Related]
30. Keratinocyte-melanocyte graft technique followed by PUVA therapy for stable vitiligo.
Kachhawa D; Kalla G
Indian J Dermatol Venereol Leprol; 2008; 74(6):622-4. PubMed ID: 19171987
[TBL] [Abstract][Full Text] [Related]
31. Experimental study and clinical observations of autologous hair follicle cell transplants to treat stable vitiligo.
Shi HX; Zhang RZ; Xu B; Xu CX; Li D; Wang L; Xiao L
Indian J Dermatol Venereol Leprol; 2020; 86(2):124-133. PubMed ID: 31397397
[TBL] [Abstract][Full Text] [Related]
32. Autologous melanocyte-keratinocyte suspension in the treatment of vitiligo.
El-Zawahry BM; Zaki NS; Bassiouny DA; Sobhi RM; Zaghloul A; Khorshied MM; Gouda HM
J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):215-20. PubMed ID: 20569286
[TBL] [Abstract][Full Text] [Related]
33. Modified technique of autologous noncultured epidermal cell transplantation for repigmenting vitiligo: a pilot study.
van Geel N; Ongenae K; De Mil M; Naeyaert JM
Dermatol Surg; 2001 Oct; 27(10):873-6. PubMed ID: 11722524
[TBL] [Abstract][Full Text] [Related]
34. Pigment cell transplantation for treatment of vitiligo: a progress report.
Löntz W; Olsson MJ; Moellmann G; Lerner AB
J Am Acad Dermatol; 1994 Apr; 30(4):591-7. PubMed ID: 8157785
[TBL] [Abstract][Full Text] [Related]
35. Melanocyte transplantation for the treatment of vitiligo: effects of different surgical techniques.
Issa CM; Rehder J; Taube MB
Eur J Dermatol; 2003; 13(1):34-9. PubMed ID: 12609779
[TBL] [Abstract][Full Text] [Related]
36. The Treatment of Refractory Vitiligo With Autologous Cultured Epithelium Grafting: A Real-World Retrospective Cohort Study.
Li J; Zeng X; Chen S; Tang L; Zhang Q; Lv M; Lian W; Wang J; Lv H; Liu Y; Shen J; Uyama T; Wu F; Wu J; Xu J
Stem Cells Transl Med; 2024 May; 13(5):415-424. PubMed ID: 38513284
[TBL] [Abstract][Full Text] [Related]
37. Treatment of vitiligo lesions by ReCell vs. conventional melanocyte-keratinocyte transplantation: a pilot study.
Mulekar SV; Ghwish B; Al Issa A; Al Eisa A
Br J Dermatol; 2008 Jan; 158(1):45-9. PubMed ID: 17927795
[TBL] [Abstract][Full Text] [Related]
38. Clinical Application of Cultured Stratified Epithelial Sheets Grown Under Feeder or Feeder-Free Conditions for Stable Vitiligo.
Li J; Chen S; Uyama T; Wu W; Xu J
Dermatol Surg; 2019 Apr; 45(4):497-505. PubMed ID: 30096104
[TBL] [Abstract][Full Text] [Related]
39. Long-term follow-up study of 142 patients with vitiligo vulgaris treated by autologous, non-cultured melanocyte-keratinocyte cell transplantation.
Mulekar SV
Int J Dermatol; 2005 Oct; 44(10):841-5. PubMed ID: 16207186
[TBL] [Abstract][Full Text] [Related]
40. Vitiligo Surgery: Shuffling Melanocytes.
Nahhas AF; Mohammad TF; Hamzavi IH
J Investig Dermatol Symp Proc; 2017 Oct; 18(2):S34-S37. PubMed ID: 28941491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
